Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Emergence of increased azithromycin resistance during unsuccessful treatment of Neisseria gonorrhoeae infection with azithromycin (Portland, OR, 2011).

Soge OO, Harger D, Schafer S, Toevs K, Raisler KA, Venator K, Holmes KK, Kirkcaldy RD.

Sex Transm Dis. 2012 Nov;39(11):877-9. doi: 10.1097/OLQ.0b013e3182685d2b.

PMID:
23064537
2.

Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.

Starnino S; GASP-LAC Working Group, Galarza P, Carvallo ME, Benzaken AS, Ballesteros AM, Cruz OM, Hernandez AL, Carbajal JL, Borthagaray G, Payares D, Dillon JA.

Sex Transm Dis. 2012 Oct;39(10):813-21.

PMID:
23001269
3.

Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 May 13;60(18):579-81.

4.

Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina.

Galarza PG, Alcalá B, Salcedo C, Canigia LF, Buscemi L, Pagano I, Oviedo C, Vázquez JA.

Sex Transm Dis. 2009 Dec;36(12):787-8. doi: 10.1097/OLQ.0b013e3181b61bb1.

PMID:
19734823
5.

Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland.

Palmer HM, Young H, Winter A, Dave J.

J Antimicrob Chemother. 2008 Sep;62(3):490-4. doi: 10.1093/jac/dkn235. Epub 2008 Jun 13.

PMID:
18552343
7.

The emergence of Neisseria gonorrhoeae with decreased susceptibility to Azithromycin in Kansas City, Missouri, 1999 to 2000.

McLean CA, Wang SA, Hoff GL, Dennis LY, Trees DL, Knapp JS, Markowitz LE, Levine WC.

Sex Transm Dis. 2004 Feb;31(2):73-8.

PMID:
14743069
8.

Emergence of gonococcal strains with resistance to azithromycin in Spain.

Arreaza L, Vázquez F, Alcalá B, Otero L, Salcedo C, Vázquez JA.

J Antimicrob Chemother. 2003 Jan;51(1):190-1. No abstract available.

PMID:
12493814
9.

Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States.

Katz AR, Komeya AY, Soge OO, Kiaha MI, Lee MV, Wasserman GM, Maningas EV, Whelen AC, Kirkcaldy RD, Shapiro SJ, Bolan GA, Holmes KK.

Clin Infect Dis. 2012 Mar;54(6):841-3. doi: 10.1093/cid/cir929. Epub 2011 Dec 19.

PMID:
22184617
10.

Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.

Hottes TS, Lester RT, Hoang LM, McKay R, Imperial M, Gilbert M, Patrick D, Wong T, Martin I, Ogilvie G.

Sex Transm Dis. 2013 Jan;40(1):46-51. doi: 10.1097/OLQ.0b013e31827bd64c.

PMID:
23250301
11.

Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China.

Yuan LF, Yin YP, Dai XQ, Pearline RV, Xiang Z, Unemo M, Chen XS.

Sex Transm Dis. 2011 Aug;38(8):764-8. doi: 10.1097/OLQ.0b013e318219cdb5.

PMID:
21844727
12.

Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2000 Sep 22;49(37):833-7.

13.

Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales.

Chisholm SA, Neal TJ, Alawattegama AB, Birley HD, Howe RA, Ison CA.

J Antimicrob Chemother. 2009 Aug;64(2):353-8. doi: 10.1093/jac/dkp188. Epub 2009 May 25.

PMID:
19468025
14.

[Antimicrobal resistance of Neisseria gonorrhoeae strains in Hungary].

Nemes-Nikodém É, Brunner A, Tóth B, Tóth V, Bánvölgyi A, Ostorházi E.

Orv Hetil. 2015 Feb 8;156(6):226-9. doi: 10.1556/OH.2015.30079. Hungarian.

PMID:
25639637
15.

CDC update on gonorrhea: expand treatment to limit resistance.

Campos-Outcalt D.

J Fam Pract. 2011 Dec;60(12):736-40. No abstract available.

PMID:
22163356
16.

Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.

17.

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.

Dillon JA, Li H, Sealy J, Ruben M, Prabhakar P; Caribbean GASP Network. Gonococcal Antimicrobial Surveillance Program.

Sex Transm Dis. 2001 Sep;28(9):508-14.

PMID:
11518867
18.

Characterization of azithromycin-resistant Neisseria gonorrhoeae isolated in Tokyo in 2005-2011.

Takayama Y, Nakayama S, Shimuta K, Morita-Ishihara T, Ohnishi M.

J Infect Chemother. 2014 May;20(5):339-41. doi: 10.1016/j.jiac.2014.01.007. Epub 2014 Feb 24.

PMID:
24571786
19.

Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.

Dillon JA, Rubabaza JP, Benzaken AS, Sardinha JC, Li H, Bandeira MG, dos Santos Fernando Filho E.

Sex Transm Dis. 2001 Sep;28(9):521-6.

PMID:
11518869
20.

Occurrence of high-level azithromycin-resistant Neisseria gonorrhoeae isolates in China.

Xue J, Ni C, Zhou H, Zhang C, van der Veen S.

J Antimicrob Chemother. 2015 Dec;70(12):3404-5. doi: 10.1093/jac/dkv266. Epub 2015 Aug 27. No abstract available.

PMID:
26316384

Supplemental Content

Support Center